APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pyelonephritis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pyelonephritis Drug Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchPyelonephritis Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pyelonephritis Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Pyelonephritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pyelonephritis Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pyelonephritis Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pyelonephritis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pyelonephritis Drug include Merck & Co Inc, The Medicines Company, AstraZeneca Plc, Zavante Therapeutics Inc, MerLion Pharmaceuticals Pte Ltd, Meiji Seika Pharma Co Ltd and Achaogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pyelonephritis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pyelonephritis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pyelonephritis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pyelonephritis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pyelonephritis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pyelonephritis Drug Market by Company

Merck & Co Inc

The Medicines Company

AstraZeneca Plc

Zavante Therapeutics Inc

MerLion Pharmaceuticals Pte Ltd

Meiji Seika Pharma Co Ltd

Achaogen Inc

Pyelonephritis Drug Segment by Type

Plazomicin Sulfate

Finafloxacin

Fosfomycin Tromethamine

Nacubactam

Others

Pyelonephritis Drug Segment by Application

Hospital

Clinic

Others

Pyelonephritis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyelonephritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pyelonephritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyelonephritis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pyelonephritis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pyelonephritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Plazomicin Sulfate Table 2. Major Company of Finafloxacin Table 3. Major Company of Fosfomycin Tromethamine Table 4. Major Company of Nacubactam Table 5. Major Company of Others Table 6. Global Pyelonephritis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Pyelonephritis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pyelonephritis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pyelonephritis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Pyelonephritis Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Pyelonephritis Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Pyelonephritis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pyelonephritis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pyelonephritis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Pyelonephritis Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Pyelonephritis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Pyelonephritis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Pyelonephritis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Pyelonephritis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Pyelonephritis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Pyelonephritis Drug Industry Trends Table 28. Pyelonephritis Drug Industry Drivers Table 29. Pyelonephritis Drug Industry Opportunities and Challenges Table 30. Pyelonephritis Drug Industry Restraints Table 31. Global Pyelonephritis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pyelonephritis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Pyelonephritis Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Pyelonephritis Drug Sales Share by Company (2021-2026) Table 35. Global Pyelonephritis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Pyelonephritis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pyelonephritis Drug Major Company Production Sites and Headquarters Table 38. Global Pyelonephritis Drug Company, Product Type & Application Table 39. Global Pyelonephritis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pyelonephritis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pyelonephritis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pyelonephritis Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Pyelonephritis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pyelonephritis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pyelonephritis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Pyelonephritis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Pyelonephritis Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Pyelonephritis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pyelonephritis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pyelonephritis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Pyelonephritis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Pyelonephritis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Pyelonephritis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pyelonephritis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pyelonephritis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Pyelonephritis Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Pyelonephritis Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Pyelonephritis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pyelonephritis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pyelonephritis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Pyelonephritis Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Pyelonephritis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Pyelonephritis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Pyelonephritis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Pyelonephritis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Pyelonephritis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Merck & Co Inc Company Information Table 75. Merck & Co Inc Business Overview Table 76. Merck & Co Inc Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck & Co Inc Pyelonephritis Drug Product Portfolio Table 78. Merck & Co Inc Recent Development Table 79. The Medicines Company Company Information Table 80. The Medicines Company Business Overview Table 81. The Medicines Company Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. The Medicines Company Pyelonephritis Drug Product Portfolio Table 83. The Medicines Company Recent Development Table 84. AstraZeneca Plc Company Information Table 85. AstraZeneca Plc Business Overview Table 86. AstraZeneca Plc Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Plc Pyelonephritis Drug Product Portfolio Table 88. AstraZeneca Plc Recent Development Table 89. Zavante Therapeutics Inc Company Information Table 90. Zavante Therapeutics Inc Business Overview Table 91. Zavante Therapeutics Inc Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Zavante Therapeutics Inc Pyelonephritis Drug Product Portfolio Table 93. Zavante Therapeutics Inc Recent Development Table 94. MerLion Pharmaceuticals Pte Ltd Company Information Table 95. MerLion Pharmaceuticals Pte Ltd Business Overview Table 96. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product Portfolio Table 98. MerLion Pharmaceuticals Pte Ltd Recent Development Table 99. Meiji Seika Pharma Co Ltd Company Information Table 100. Meiji Seika Pharma Co Ltd Business Overview Table 101. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product Portfolio Table 103. Meiji Seika Pharma Co Ltd Recent Development Table 104. Achaogen Inc Company Information Table 105. Achaogen Inc Business Overview Table 106. Achaogen Inc Pyelonephritis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Achaogen Inc Pyelonephritis Drug Product Portfolio Table 108. Achaogen Inc Recent Development Table 109. North America Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. North America Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 111. North America Pyelonephritis Drug Sales Market Share by Country (2021-2026) Table 112. North America Pyelonephritis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 113. North America Pyelonephritis Drug Sales Market Share Forecast by Country (2027-2032) Table 114. North America Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Pyelonephritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Pyelonephritis Drug Market Share by Country (2021-2026) Table 117. North America Pyelonephritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Pyelonephritis Drug Market Share Forecast by Country (2027-2032) Table 119. Europe Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Europe Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 121. Europe Pyelonephritis Drug Sales Market Share by Country (2021-2026) Table 122. Europe Pyelonephritis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 123. Europe Pyelonephritis Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Pyelonephritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Pyelonephritis Drug Market Share by Country (2021-2026) Table 127. Europe Pyelonephritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Pyelonephritis Drug Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 131. Asia-Pacific Pyelonephritis Drug Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Pyelonephritis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 133. Asia-Pacific Pyelonephritis Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Pyelonephritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Pyelonephritis Drug Market Share by Country (2021-2026) Table 137. Asia-Pacific Pyelonephritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Pyelonephritis Drug Market Share Forecast by Country (2027-2032) Table 139. Latin America Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Latin America Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 141. Latin America Pyelonephritis Drug Sales Market Share by Country (2021-2026) Table 142. Latin America Pyelonephritis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 143. Latin America Pyelonephritis Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Pyelonephritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Pyelonephritis Drug Market Share by Country (2021-2026) Table 147. Latin America Pyelonephritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Pyelonephritis Drug Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 151. Middle East and Africa Pyelonephritis Drug Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Pyelonephritis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 153. Middle East and Africa Pyelonephritis Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Pyelonephritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Pyelonephritis Drug Market Share by Country (2021-2026) Table 157. Middle East and Africa Pyelonephritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Pyelonephritis Drug Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Pyelonephritis Drug Distributors List Table 162. Pyelonephritis Drug Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Pyelonephritis Drug Image Figure 2. Global Pyelonephritis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pyelonephritis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Pyelonephritis Drug Sales (2021-2032) & (K Units) Figure 5. Plazomicin Sulfate Image Figure 6. Global Plazomicin Sulfate Sales YoY Growth (2021-2032) & (K Units) Figure 7. Finafloxacin Image Figure 8. Global Finafloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Fosfomycin Tromethamine Image Figure 10. Global Fosfomycin Tromethamine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Nacubactam Image Figure 12. Global Nacubactam Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Pyelonephritis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pyelonephritis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Pyelonephritis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Pyelonephritis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Pyelonephritis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pyelonephritis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pyelonephritis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pyelonephritis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pyelonephritis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pyelonephritis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pyelonephritis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pyelonephritis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pyelonephritis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Pyelonephritis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pyelonephritis Drug Market Share by Application 2025 VS 2032 Figure 37. North America Pyelonephritis Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Pyelonephritis Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Pyelonephritis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Pyelonephritis Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Pyelonephritis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Pyelonephritis Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Pyelonephritis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Pyelonephritis Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Pyelonephritis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Pyelonephritis Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Pyelonephritis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Pyelonephritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Pyelonephritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Pyelonephritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pyelonephritis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Pyelonephritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pyelonephritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Pyelonephritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pyelonephritis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Pyelonephritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pyelonephritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Pyelonephritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pyelonephritis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Pyelonephritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pyelonephritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Pyelonephritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pyelonephritis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Pyelonephritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pyelonephritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Pyelonephritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pyelonephritis Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Pyelonephritis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plazomicin Sulfate
  • Finafloxacin
  • Fosfomycin Tromethamine
  • Nacubactam
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Merck & Co Inc
  • The Medicines Company
  • AstraZeneca Plc
  • Zavante Therapeutics Inc
  • MerLion Pharmaceuticals Pte Ltd
  • Meiji Seika Pharma Co Ltd
  • Achaogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pyelonephritis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pyelonephritis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pyelonephritis Drug Market by Type
  6. 1.3.1 Plazomicin Sulfate
  7. 1.3.2 Finafloxacin
  8. 1.3.3 Fosfomycin Tromethamine
  9. 1.3.4 Nacubactam
  10. 1.3.5 Others
  11. 1.4 Global Pyelonephritis Drug Market Size by Type
  12. 1.4.1 Global Pyelonephritis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pyelonephritis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pyelonephritis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pyelonephritis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pyelonephritis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pyelonephritis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pyelonephritis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pyelonephritis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pyelonephritis Drug Industry Trends
  2. 2.2 Pyelonephritis Drug Industry Drivers
  3. 2.3 Pyelonephritis Drug Industry Opportunities and Challenges
  4. 2.4 Pyelonephritis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pyelonephritis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Pyelonephritis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Pyelonephritis Drug Price (2021-2026)
  4. 3.4 Global Pyelonephritis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pyelonephritis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Pyelonephritis Drug Company, Product Type & Application
  7. 3.7 Global Pyelonephritis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pyelonephritis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pyelonephritis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pyelonephritis Drug Tier 1, Tier 2, and Tier 3
4 Pyelonephritis Drug Regional Status and Outlook
  1. 4.1 Global Pyelonephritis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pyelonephritis Drug Historic Market Size by Region
  3. 4.2.1 Global Pyelonephritis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pyelonephritis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pyelonephritis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pyelonephritis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Pyelonephritis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pyelonephritis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pyelonephritis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pyelonephritis Drug by Application
  1. 5.1 Pyelonephritis Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Pyelonephritis Drug Market Size by Application
  6. 5.2.1 Global Pyelonephritis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pyelonephritis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pyelonephritis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pyelonephritis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pyelonephritis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pyelonephritis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pyelonephritis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pyelonephritis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co Inc
  2. 6.1.1 Merck & Co Inc Company Information
  3. 6.1.2 Merck & Co Inc Business Overview
  4. 6.1.3 Merck & Co Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co Inc Pyelonephritis Drug Product Portfolio
  6. 6.1.5 Merck & Co Inc Recent Developments
  7. 6.2 The Medicines Company
  8. 6.2.1 The Medicines Company Company Information
  9. 6.2.2 The Medicines Company Business Overview
  10. 6.2.3 The Medicines Company Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 The Medicines Company Pyelonephritis Drug Product Portfolio
  12. 6.2.5 The Medicines Company Recent Developments
  13. 6.3 AstraZeneca Plc
  14. 6.3.1 AstraZeneca Plc Company Information
  15. 6.3.2 AstraZeneca Plc Business Overview
  16. 6.3.3 AstraZeneca Plc Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Plc Pyelonephritis Drug Product Portfolio
  18. 6.3.5 AstraZeneca Plc Recent Developments
  19. 6.4 Zavante Therapeutics Inc
  20. 6.4.1 Zavante Therapeutics Inc Company Information
  21. 6.4.2 Zavante Therapeutics Inc Business Overview
  22. 6.4.3 Zavante Therapeutics Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zavante Therapeutics Inc Pyelonephritis Drug Product Portfolio
  24. 6.4.5 Zavante Therapeutics Inc Recent Developments
  25. 6.5 MerLion Pharmaceuticals Pte Ltd
  26. 6.5.1 MerLion Pharmaceuticals Pte Ltd Company Information
  27. 6.5.2 MerLion Pharmaceuticals Pte Ltd Business Overview
  28. 6.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product Portfolio
  30. 6.5.5 MerLion Pharmaceuticals Pte Ltd Recent Developments
  31. 6.6 Meiji Seika Pharma Co Ltd
  32. 6.6.1 Meiji Seika Pharma Co Ltd Company Information
  33. 6.6.2 Meiji Seika Pharma Co Ltd Business Overview
  34. 6.6.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product Portfolio
  36. 6.6.5 Meiji Seika Pharma Co Ltd Recent Developments
  37. 6.7 Achaogen Inc
  38. 6.7.1 Achaogen Inc Company Information
  39. 6.7.2 Achaogen Inc Business Overview
  40. 6.7.3 Achaogen Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Achaogen Inc Pyelonephritis Drug Product Portfolio
  42. 6.7.5 Achaogen Inc Recent Developments
7 North America by Country
  1. 7.1 North America Pyelonephritis Drug Sales by Country
  2. 7.1.1 North America Pyelonephritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pyelonephritis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Pyelonephritis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pyelonephritis Drug Market Size by Country
  6. 7.2.1 North America Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pyelonephritis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Pyelonephritis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pyelonephritis Drug Sales by Country
  2. 8.1.1 Europe Pyelonephritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pyelonephritis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Pyelonephritis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pyelonephritis Drug Market Size by Country
  6. 8.2.1 Europe Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pyelonephritis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pyelonephritis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pyelonephritis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Pyelonephritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pyelonephritis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pyelonephritis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pyelonephritis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pyelonephritis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pyelonephritis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pyelonephritis Drug Sales by Country
  2. 10.1.1 South America Pyelonephritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pyelonephritis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Pyelonephritis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pyelonephritis Drug Market Size by Country
  6. 10.2.1 South America Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pyelonephritis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Pyelonephritis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pyelonephritis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Pyelonephritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pyelonephritis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pyelonephritis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pyelonephritis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Pyelonephritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pyelonephritis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pyelonephritis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pyelonephritis Drug Value Chain Analysis
  2. 12.1.1 Pyelonephritis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pyelonephritis Drug Production Mode & Process
  7. 12.2 Pyelonephritis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pyelonephritis Drug Distributors
  10. 12.2.3 Pyelonephritis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst